Representative render — packaging may vary
Retatrutide
Also indexed as LY3437943 · GGG tri-agonist
All products currently listed on this site are for research purposes only.
A triple agonist peptide acting at the GLP-1, GIP and glucagon receptors — the most-watched compound in current metabolic research.
Size
$159.00
per unit · EP-RET-005
Add 2 more to reach $145.00 per unit.
| Quantity | Unit price | Saving |
|---|---|---|
| 1–2 | $159.00 | — |
| 3+ | $145.00 | 9% |
| 5+ | $132.00 | 17% |
Certificate of analysis
Lot EP-RET-2606A
99.1%
Assayed purity
Guaranteed floor 99%
- Tested
- June 28, 2026
- Laboratory
- Janoshik Analytical
- Methods
- HPLCLC-MS
Literature
Research context
Retatrutide is a synthetic peptide engineered for simultaneous agonism at three incretin and glucagon-family receptors. It is the subject of active phase-II and phase-III clinical investigation by its originator; published trial data concerns metabolic endpoints under controlled medical supervision. Supplied here strictly as a reference material for in-vitro receptor and signalling work.
Documented research areas
- GLP-1 receptor agonism
- GIP receptor agonism
- Glucagon receptor signalling
- Comparative incretin pharmacology
Specification
Chemistry
- CAS number
- 2381089-83-2
- Molecular formula
- C221H342N46O68
- Molecular weight
- 4731.3 g/mol
- Form
- Lyophilized powder
- Purity floor
- ≥ 99%
- Appears in
- 4 documented research areas
Laboratory
Storage and handling
Storage
Store lyophilized powder at -20°C, protected from light and moisture.
Handling
For laboratory use by qualified personnel only. Investigational compound — handle under appropriate containment.
Research use only. This material is supplied for laboratory research by qualified personnel. It is not a drug, food, cosmetic or household product, and it is not for human or veterinary use. See our research use policy and prohibited uses.
Sources
Selected references
External links open in a new tab. Ethereal Peptides is not affiliated with the publishers or the authors listed.
Nearby
Studied alongside
Incretin & Metabolic5-Amino-1MQ
5-amino-1-methylquinolinium
A quaternary quinolinium small molecule described in the literature as a selective inhibitor of nicotinamide N-methyltransferase.
Capsule≥98.5% purityLot assayed 99%From
$59.00
2 sizes
Research Use Only- Incretin & Metabolic
Tesofensine
NS2330
A tropane-derived small molecule characterised in the literature as a triple reuptake inhibitor of noradrenaline, dopamine and serotonin.
Capsule≥98.5% purityLot assayed 98.9%From
$89.00
1 size
Research Use Only 
NewIncretin & MetabolicSurvodutide
BI 456906
A 29-residue dual agonist of the glucagon and GLP-1 receptors carrying a C18 fatty-acid conjugate.
Lyophilized powder≥99% purityLot assayed 98.8%From
$139.00
1 size
Research Use Only